Nigel is a senior partner in the firm’s Intellectual Property (IP) group and widely acknowledged as a leading practitioner in IP law. He counsels corporates on IP disputes, particularly involving patents, and has extensive experience coordinating teams advising on complex, high-profile, cross-border disputes. Nigel’s qualification and experience as a mediator is frequently called upon to help resolve disputes.
Nigel also regularly advises on the IP dimensions of multiparty, cross-border corporate transactions.
Building on his science background, Nigel established the firm’s healthcare sector group, and led it for 20 years. He also ran a five-year programme of roundtables on sustainable innovation in healthcare.
Nigel has led, or advised, on many of the market’s most significant transactions and cases. Highlights include advising:
- J&J in cross-border disputes relating to patents for four monoclonal antibody-based therapeutics, Simponi, Remicade, solanezumab and Stelara
- Sanofi and Regeneron on several cross-border monoclonal antibody disputes, including co-ordinating cross-border legal teams and representing them in UK proceedings
- Shire on numerous patent disputes including those in relation to Reminyl, GA-GeP and a potential treatment for Wolman’s disease
- Zeneca on the disposal of its specialty chemicals business
- a multinational pharmaceutical company on the IP aspects of its transformational restructuring involving three strategic deals with a UK based pharmaceutical company
- the seller on negotiating a long-term brand licence to the purchaser of Rio Tinto’s engineered products division
- brand owners considering granting a licence to a Chinese joint venture in both automotive and construction equipment sectors
Nigel co-founded and chairs the City Mental Health Alliance, a coalition of organisations that have come together to create an environment in the City where mental health is discussed in the same way as physical health. He is a lay trustee of the Royal College of Psychiatrists and is also a director of the Orchestra of the Age of Enlightenment.
Previously, Nigel was a board member of Participle, which aimed to create new kinds of public service. He was also president of the Licensing Executives Society, Britain & Ireland, the leading association for people involved in technology transfer and the exploitation of intellectual property.
Education and qualifications
Nigel studied biochemistry at Brasenose College, Oxford University.
He speaks English, French and (some) German.